Accountability Life Sciences Pharmaceuticals Regulations 
HIT Consultant
JUNE 29, 2022
The Covid-19 pandemic has led to a surge in innovation across the life sciences industry, including vaccines and treatments being developed, approved, manufactured and delivered at an unprecedented scale in a matter of months – truly a remarkable achievement, and a testament to human ingenuity. About Annette Williams.
HIT Consultant
JULY 25, 2022
Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
JUNE 18, 2024
What You Should Know: – Mika Health , a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called “UNITE” alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo. million new cases were diagnosed, accounting for one in four new cancer cases.
Health Populi
APRIL 24, 2019
Given tone and tenor of the day, and particularly among mass population, healthcare may continue to see increasing demands for change and regulation,” Susan Isenberg, Edelman’s head of healthcare, notes in her observations of the 2019 Edelman Trust Barometer. What might account for this drop in trust for healthcare providers?
HIT Consultant
OCTOBER 5, 2022
For pharmaceutical manufacturing firms, the amount of documentation required around state price transparency regulations continues to expand. Federal regulations are a long way off, and state-by-state reporting requirements are no longer “cut and paste” affairs that can be satisfied with a canned set of reports.
Health Populi
OCTOBER 8, 2019
Thus, administrative complexity, which includes billing and coding waste, and physician time spent reporting on quality measures, accounted for the largest component of waste in American health care. Pricing failure as a waste-factor accounted for nearly another third of total waste in U.S. medical spending. health care.
HIT Consultant
NOVEMBER 2, 2022
The European Union (EU) has announced guidance on the Identification of Medicinal Product (IDMP) — and pharmaceutical companies around the world should take notice. It’s imperative that companies begin evaluating what changes need to be implemented, and the sooner pharmaceutical companies act, the better. This is no small feat.
Expert insights. Personalized for you.
98 
Let's personalize your content